8th Annual Blueprint for Breakthrough Forum | Friends of Cancer Research

You are here

8th Annual Blueprint for Breakthrough Forum


8th Annual Blueprint for Breakthrough Forum
Validating Real-World Endpoints for an Evolving Regulatory Landscape 

Featuring Keynotes from:
Dr. Ned Sharpless
Acting Commissioner, U.S. FDA
Dr. Amy Abernethy

Principal Deputy Commissioner, U.S. FDA

The Ritz-Carlton
1150 22nd St NW
Washington, DC 20037

Wednesday, September 18, 2019
8:30 AM EDT - 3:00 PM EDT


 Register Today!


Friends of Cancer Research (Friends) and Alexandria Real Estate Equities, Inc. (Alexandria) are proud to announce the eighth annual Blueprint for Breakthrough forum. Friends and Alexandria will convene stakeholders across academia, government, industry, research and advocacy organizations, and other interested groups with the intent of developing consensus on critical aspects of validating real-world endpoints (rwEndpoints) for an evolving regulatory landscape. 


For more information on the project, please click HERE. Scroll through below for the draft agenda. 


Register by clicking above! If you have any questions, please contact Heather Chaney at (202) 944-6719 or hchaney@focr.org.


Draft Agenda


8:30 AM - Registration and Breakfast

9:00 AM - Welcoming Remarks

  • Ellen Sigal, Friends of Cancer Research
  • Lynne Zydowsky, Alexandria Real Estate Equities, Inc.

9:05 AM - Morning Keynote Conversation

  • Dr. Ned Sharpless, Acting Commissioner, U.S. Food and Drug Administration

9:35 AM - Pilot Project Findings: Evaluating Real-World Endpoints

  • Jeff Allen, Friends of Cancer Research

10:00 AM - Panel 1: Operationalizing the Use of Real-World Datasets


11:15 AM - Break

11:30 AM - Panel 2: Developing a Validation Framework for Real-World Data

12:45 PM - Lunch

1:15 PM - Lunch Keynote Conversation

  • Dr. Amy Abernethy, Principal Deputy Commissioner, U.S. Food and Drug Administration

1:45 PM - Panel 3: The Future of Real-World Evidence: Informing Regulatory and Payer Decisions


3:00 PM - Closing Remarks

Wednesday, September 18, 2019 -
8:30am to 3:00pm
Event Type: